Kazia Therapeutics Stock Australian S.E.
Equities
KZA
AU000000KZA9
Biotechnology & Medical Research
Sales 2022 | 10K 6.6K | Sales 2023 | 555 366.4 | Capitalization | 39.72M 26.22M |
---|---|---|---|---|---|
Net income 2022 | -24M -15.84M | Net income 2023 | -20M -13.2M | EV / Sales 2022 | 7,714 x |
Net cash position 2022 | 7.36M 4.86M | Net cash position 2023 | 3.44M 2.27M | EV / Sales 2023 | 65,355 x |
P/E ratio 2022 |
-3.27
x | P/E ratio 2023 |
-1.55
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.6% |
Latest transcript on Kazia Therapeutics
1st Jan change | Capi. | |
---|---|---|
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+41.87% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |